Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative

Details for Australian Patent Application No. 2007259122 (hide)

International Classifications

Event Publications

15 January 2009 PCT application entered the National Phase

PCT publication WO2007/144493 Priority application(s): WO2007/144493

18 October 2012 Alteration of Name

The name of the applicant has been altered to Ipsen Pharma S.A.S.

1 November 2012 Application Accepted

Published as AU-B-2007259122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.